Skip to main content
. 2021 Oct 19;12:692079. doi: 10.3389/fimmu.2021.692079

Figure 4.

Figure 4

Associations of the Ti-lncRNA signature with DFS in patients from TCGA and FUSCC. (A–D) Differences in DFS and the predictive effect of the signature risk score were analyzed in TCGA cohort (A, B) and in the FUSCC cohort (C, D). lncRNA, long non-coding RNA; Ti-lncRNA, tumor-infiltrating immune-related lncRNA; DFS, disease-free survival; TCGA, The Cancer Genome Atlas; FUSCC, Fudan University Shanghai Cancer Center.